FDA Cites PET Drugmaker for Testing, Sterility Practices

Drug Industry Daily
A A
The FDA hit PET drug manufacturer 3D Imaging Drug Design and Development with a Form 483 for testing and sterility violations.

To View This Article:

Login

Subscribe To Drug Industry Daily